Preferred Label : Proprotein Convertase 9;

MeSH definition : A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the LDL RECEPTOR (LDLR); the VLDL receptor, and the APOLIPOPROTEIN E RECEPTOR. It also regulates neuronal APOPTOSIS.;

MeSH synonym : Convertase 9, Proprotein; Neural Apoptosis-Regulated Convertase 1; Neural Apoptosis Regulated Convertase 1; NARC-1 Protein; NARC 1 Protein; Proprotein Convertase, Subtilisin-Kexin Type 9; Proprotein Convertase, Subtilisin Kexin Type 9;

Registry Number MeSH : EC 3.4.21.-;

Details


Main resources

You can consult :

A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the LDL RECEPTOR (LDLR); the VLDL receptor, and the APOLIPOPROTEIN E RECEPTOR. It also regulates neuronal APOPTOSIS.

https://pharmacomedicale.org/component/zoo/item/anti-pcsk9
2022
France
scientific and technical information
Proprotein Convertase 9

---
https://www.cochrane.org/fr/CD011748/VASC_inhibiteurs-de-la-pcsk9-pour-la-prevention-des-maladies-cardiovasculaires
2020
false
false
false
France
United Kingdom
Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance)
Proprotein Convertase 9
treatment outcome
Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action (substance)
cholesterol, LDL
alirocumab
evolocumab
Evidence-Based medicine
review of literature
french abstract
cardiovascular diseases
cardiovascular prevention
antibodies, monoclonal

---
https://www.revmed.ch/RMS/2017/RMS-N-558/Inhibiteurs-de-la-PCSK9
2017
false
false
false
Switzerland
French
journal article
Proprotein Convertase 9
Proprotein Convertase 9
anticholesteremic agents
anticholesteremic agents
cardiovascular diseases
risk factors
cholesterol, LDL
At increased risk for cardiovascular event (finding)
hydroxymethylglutaryl-coa reductase inhibitors
hypercholesterolemia
Proprotein Convertase 9
mutation
alirocumab
evolocumab
PCSK9 protein, human
bococizumab
comparative effectiveness research
high serum cholesterol, familial
antibodies, monoclonal
serine endopeptidases
proprotein convertases
antibodies, monoclonal, humanized
hyperlipoproteinemia type ii

---
http://www.sfendocrino.org/_images/mediatheque/articles/pdf/Gueritee/Guer2015/2015_verges_bruno.pdf
2015
France
scientific and technical information
blood group antibody je a
blood group antibody wk a
blood group antibody li a
blood group antibody mi a
blood group antibody es a
blood group antibody jn a
blood group antibody le bh
ldl cholesterol
blood group antibody en afs
blood group antibody ls a
blood group antibody sk a
blood group antibody cl a
blood group antibody dh a
blood group antibody kn a
blood group antibody cs a
blood group antibody a1 le d
hospitals, proprietary
antibodies
blood group antibody a.m.
blood group antibody tr a
blood group antibody er a
blood group antibody do a
blood group antibody a1
blood group antibody ht a
blood group antibody m1a
blood group antibody rg a
blood group antibody dr a
blood group antibody au a
blood group antibody gy a
blood group antibody lw a
cholesterol, LDL
blood group antibody jk a
blood group antibody a.m.
blood group antibody a3
blood group antibody hg a
blood group antibody di a
blood group antibody s1a
blood group antibody n a
blood group antibody c
blood group antibody a2
blood group antibody fy a
blood group antibody en ats
antibody, nos
blood group antibody re a
blood group antibody le a
blood group antibody vg a
blood group antibody wr a
blood group antibody js a
blood group antibody pr a
blood group antibody vr
blood group antibody pr a
blood group antibody c
blood group antibody th a
blood group antibody bx a
blood group antibody bp a
blood group antibody fr a
blood group antibody sc2
blood group antibody ri a
blood group antibody mt a
blood group antibody rh a
blood group antibody xg a
blood group antibody a1 le b
blood group antibody ok a
blood group antibody en afr
blood group antibody r1a
blood group antibody kp a
blood group antibody chr a
blood group antibody ny a
blood group antibody a x
blood group antibody jc a
blood group antibody le x
endocrinology
blood group antibody tg a
blood group antibody le bl
blood group antibody lan
blood group antibody in a
blood group antibody lu a
blood group antibody or a
blood group antibody wd a
blood group antibody m'
blood group antibody co a
blood group antibody to a
blood group antibody le c
blood group antibody st a
blood group antibody en akt
blood group antibody yh a
blood group antibody nijhuis
blood group antibody os a
blood group antibody rd a
blood group antibody ol a
blood group antibody ch a
blood group antibody cr3
blood group antibody m a
blood group antibody jo a
antibodies, anti-idiotypic
blood group antibody tj a
blood group antibody bg a
Proprotein Convertase 9
blood group antibody le s
blood group antibody pt a
blood group antibody go a
blood group antibody mo a
blood group antibody 'n'
blood group antibody an a
blood group antibody be a
blood group antibody at a
blood group antibody u1a
blood group antibody sw a
blood group antibody le d
blood group antibody le ns
blood group antibody sf a
blood group antibody sd a
blood group antibody zt a
blood group antibody rh42
blood group antibody jr a
blood group antibody lw b
blood group antibody yk a
blood group antibody le b
blood group antibody rb a
blood group antibody yt a
blood group antibody mcc a

---
Nous contacter.
17/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.